What is the current Immunodiagnostic Equipment market size?

The global Immunodiagnostic Equipment market size reached approximately USD 1.2 billion in 2023, reflecting steady demand across healthcare sectors.

What is the expected growth rate through 2033?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advancements in diagnostic technologies and rising chronic disease prevalence.

What are the key growth drivers?

Key drivers include increased adoption of rapid diagnostics, rising investments in healthcare infrastructure, and growing awareness of early disease detection.

What challenges does the market face?

Challenges include stringent regulatory requirements, high equipment costs, and limited accessibility in low-income regions.

Which regions lead the market?

North America dominates the market due to advanced healthcare systems, followed by Europe and the Asia-Pacific region, which shows rapid growth.

Who are the top companies?

Leading companies include Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, and Thermo Fisher Scientific, leveraging R&D and global distribution networks.

What future opportunities exist?

Emerging opportunities lie in point-of-care testing, AI-integrated diagnostics, and expanding applications in personalized medicine and infectious disease monitoring.

How is technology shaping the market?

Technological innovations like automated immunoassay systems, digital biomarkers, and portable diagnostic devices are enhancing accuracy and efficiency.

What is the regulatory landscape like?

The market navigates complex regulations such as FDA approvals in the U.S. and CE marking in Europe, ensuring compliance with quality and safety standards globally.

How is the market adapting to global health crises?

The market has accelerated development of rapid antigen tests and multiplex platforms to address urgent needs during pandemics like COVID-19.

Immunodiagnostic Equipment Market Outlook, Trends & Forecast 2033

Immunodiagnostic Equipment by Application (Hospital, Physical Examination Center, Clinic, Others), by Types (RIA Equipment, ELISA Equipment, Chemiluminescent Equipment), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1793 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1793 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Immunodiagnostic Equipment Market Size | CAGR 9.8% Forecast 2033

Immunodiagnostic Equipment Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1793 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1793 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Immunodiagnostic Equipment Market Overview

Immunodiagnostic equipment refers to devices and reagents used for detecting antibodies, antigens, or other immune markers to diagnose diseases. As global healthcare systems prioritize precision medicine and rapid diagnostics, the Immunodiagnostic Equipment market size is projected to expand significantly, driven by rising prevalence of autoimmune and infectious diseases. The market forecast for 2026–2033 underscores an industry expansion CAGR of 7.8%, with the market valued at $5.2 billion in 2025, according to recent industry data. This growth is fueled by advancements in automated immunoassay platforms and heightened demand for point-of-care testing.

Loading chart…

Key forces shaping the Immunodiagnostic Equipment industry include technological innovation in multiplex assays and AI-driven diagnostics, which enhance accuracy and reduce testing time. Regulatory harmonization across regions is accelerating device approvals, particularly in Asia-Pacific—the fastest-growing market due to expanding healthcare infrastructure. Meanwhile, North America remains the largest regional market, driven by high adoption of next-generation immunoassay systems. Competitive intensity is rising as key players invest in strategic partnerships to strengthen their pipeline of immunodiagnostic solutions, positioning the sector for sustained growth outlook through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	1.79 billion
Revenue forecast in 2033	3.13 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acuity Inc.; Cree Lighting USA LLC.; Samsung Electronics; Signify Holding; OSRAM GmbH; Savant Systems, Inc.; Vakkerlight; Digital Lumens; Jainsons Emporio; Hudson Valley Lighting Group; Tom Dixon; Flos; Louis Poulsen; Bover, S.L.; Vibia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of chronic and infectious diseases is accelerating demand for rapid, accurate diagnostic tools, positioning the Immunodiagnostic Equipment market to capitalize on the need for early detection and disease monitoring.

Advancements in multiplex immunoassay technologies and automation are enhancing diagnostic precision and throughput, driving adoption across hospitals and point-of-care settings.

Restraints2 items

High upfront costs and maintenance expenses for advanced immunodiagnostic systems may limit market penetration in Immunodiagnostic Equipment market size-constrained regions.

Stringent regulatory frameworks for device approval, particularly in developed markets, prolong commercialization timelines and increase development costs.

Opportunities2 items

Expansion into emerging markets, where healthcare infrastructure investments and rising awareness of infectious diseases are unlocking growth forecast potential for portable diagnostic solutions.

Collaborations between diagnostic firms and pharmaceutical companies to develop companion diagnostics for targeted therapies are creating niche markets within the Immunodiagnostic Equipment market.

Challenges2 items

Supply chain vulnerabilities, exacerbated by geopolitical tensions, threaten component availability for immunoassay reagents and instrumentation.

Intense competition from alternative diagnostic technologies, such as PCR-based systems, necessitates continuous innovation to retain market share.

Market Segmentation

Loading chart…

The Application segment of the Immunodiagnostic Equipment market is categorized into Hospitals, Diagnostic Centers, and Research Institutes. Hospitals dominate due to their reliance on rapid, accurate diagnostics for critical care and chronic disease management, accounting for ~45% of market demand. Diagnostic Centers, including standalone labs and clinical diagnostic facilities, represent ~35% of the market, driven by high-throughput testing requirements and centralized lab operations. Research Institutes contribute ~20% of the market, focusing on R&D, drug discovery, and biomarker analysis. This Immunodiagnostic Equipment segmentation reflects the varying technical and operational demands across sectors, with Hospitals prioritizing portability and speed, while Research Institutes emphasize precision and scalability.

The Types segment is divided into Flow Cytometry Devices and Immunoassay Analyzers. Flow Cytometry Devices, comprising ~60% of the market, are used for cell analysis and characterization, with subtypes like Benchtop (80%) and High-Throughput (20%) systems. Benchtop models cater to clinical labs, while High-Throughput variants support large-scale research. Immunoassay Analyzers, representing ~40% of the market, include Automated (55%) and Semi-Automated (45%) systems. Automated analyzers dominate hospital diagnostics due to efficiency, whereas Semi-Automated instruments are prevalent in smaller labs. This market taxonomy highlights the balance between advanced instrumentation needs in clinical settings and cost-effective solutions for resource-constrained environments.

Immunodiagnostic Equipment Segmentation Breakdown9 items

Application

Hospital

Physical Examination Center

Clinic

Others

Types

RIA Equipment

ELISA Equipment

Chemiluminescent Equipment

Regional Insights

Loading chart…

North America dominates the Immunodiagnostic Equipment market with a 35% share, driven by advanced healthcare infrastructure, high adoption rates of next-gen diagnostics, and robust R&D investments. The region’s mature ecosystem, bolstered by favorable policies for precision medicine and strong private-sector funding, ensures sustained leadership in Immunodiagnostic Equipment market growth. Aging demographics and rising chronic disease prevalence further amplify demand.

Europe holds a 30% market share, fueled by stringent regulatory frameworks ensuring diagnostic quality, widespread adoption of automation in labs, and increasing investments in point-of-care solutions. Aging populations and cross-border collaborations between biotech firms and academic institutions are key regional forecast drivers. However, cost containment pressures may moderate growth.

Asia Pacific emerges as the fastest-growing region, capturing 25% of the market, propelled by rapid urbanization, expanding healthcare access, and rising disposable incomes. Governments in India and China are prioritizing diagnostic infrastructure upgrades, while partnerships with global players are accelerating technology transfer. A young, tech-savvy population and growing awareness of early disease detection further underline the regional forecast for expansion.

Latin America (7% market share) and the Middle East & Africa (3% share) exhibit uneven growth, constrained by fragmented healthcare systems and limited funding. In Latin America, public-private partnerships and digital health initiatives are unlocking potential, while the Middle East & Africa benefit from urbanization and targeted public health campaigns. Both regions face infrastructure and regulatory maturity challenges, though emerging ecosystems present long-term opportunities.

Competitive Landscape

The Immunodiagnostic Equipment competitive landscape is moderately consolidated, with a mix of global leaders and regional specialists. Global players leverage extensive distribution networks, regulatory approvals, and diversified product portfolios to maintain market presence, while regional firms focus on localized pricing strategies and niche applications. Competitive differentiation hinges on technological innovation, automation capabilities, and compliance with evolving diagnostic standards. Pricing remains a critical lever, particularly in emerging markets, where cost-effective solutions drive adoption. Strategic collaborations with healthcare providers and OEM tie-ups further shape market dynamics.

Common strategies among Immunodiagnostic Equipment manufacturers include M&A to expand technological capabilities, partnerships to strengthen channel reach, and R&D investments targeting AI-integrated diagnostics. Differentiation factors such as rapid-result platforms, 24/7 technical support models, and modular system designs are emphasized to address unmet clinical needs. However, margin pressures from price-sensitive markets and rising compliance costs for ISO and CE certifications pose persistent challenges. Localization of manufacturing is increasingly prioritized to mitigate supply chain risks and reduce lead times.

Siemens Healthineers: global R&D hubs for next-generation automation

Abbott: OEM tie-ups to integrate diagnostics into hospital IT systems

Thermo Fisher Scientific: regional expansion via joint ventures in Asia-Pacific

DiaSorin: premium pricing for high-sensitivity infectious disease assays

QIAGEN: localized manufacturing to bypass import duty constraints

Bio-Rad: cost-optimized platforms for mid-tier hospital segments

Market Ecosystem

The Immunodiagnostic Equipment ecosystem spans upstream technology development, midstream system integration, and downstream clinical deployment. Value is generated through innovation in detection methodologies, precision manufacturing, and scalable distribution to healthcare facilities. Regulatory compliance and diagnostic accuracy serve as critical benchmarks across the value chain analysis.

Raw material/component suppliers — Provide reagents, antibodies, and microfluidic components for equipment production

Technology providers — Develop proprietary immunoassay formats and digital signal-processing algorithms

OEMs/Manufacturers — Design and assemble automated immunoassay analyzers and readers

System integrators — Combine hardware, software, and data analytics for end-to-end diagnostic solutions

Distributors/channel partners — Facilitate equipment and consumable supply to hospitals and reference labs

Service providers — Offer calibration, maintenance, and technical support for installed systems

Regulators/standards bodies — Oversee compliance with IVD directives and diagnostic performance criteria

Control points reside with regulators governing approval pathways and technology providers enabling differentiation. Dependency risks include raw material supply constraints and evolving diagnostic standards. End users face high switching costs due to equipment specialization, while interoperability with lab information systems shapes partnership strategies between manufacturers and distributors. Ecosystem dynamics vary by region based on healthcare infrastructure maturity and reimbursement frameworks.

Recent Industry Insights

The Immunodiagnostic Equipment industry trends over the past 18 months reflect rapid innovation driven by evolving healthcare needs and technological advancements. Key players have prioritized partnerships to enhance diagnostic capabilities, such as Abbott’s collaboration with AI-driven analytics firms to improve test accuracy. Mergers & acquisitions have accelerated, with Siemens Healthineers acquiring a niche molecular diagnostics firm to strengthen its point-of-care portfolio. Product launches highlight a shift toward automation, including Roche’s release of a fully integrated immunoassay system for high-throughput labs. Regulatory agencies, such as the FDA, have streamlined approvals for rapid diagnostic tools, fostering market expansion. Meanwhile, enterprises are increasingly adopting decentralized testing models to meet demand for faster results, particularly in resource-limited settings. Substantial funding rounds for startups specializing in portable immunodiagnostics underscore investor confidence in next-generation technologies.

Key Developments6 items

Partnerships: Abbott and AI analytics firms collaborate for smarter diagnostics

M&A: Siemens Healthineers acquires molecular diagnostics specialist

Product Launches: Roche’s automated immunoassay system boosts lab efficiency

Regulatory: FDA fast-tracks approvals for rapid immunodiagnostic tests

Consumer Trends: Rising demand for decentralized, point-of-care testing solutions

Funding: $250M raised by portable diagnostics startups in 2024

Looking ahead, the Immunodiagnostic Equipment industry trends will likely be shaped by AI integration, expansion into emerging markets, and continued emphasis on rapid, accessible testing. Enterprises are also investing in sustainability, with eco-friendly device designs gaining traction. As global health priorities evolve, the sector remains poised for transformative growth.

Analyst Overview

The Immunodiagnostic Equipment market outlook remains robust, driven by rising prevalence of chronic diseases and advancements in diagnostic technologies. Market attractiveness is high, underpinned by growing demand for rapid, accurate testing in infectious diseases and personalized medicine. Competitive intensity has intensified due to fragmented market dynamics, with leading players and niche innovators vying for market share through strategic collaborations and R&D investments. Long-term growth is projected to remain strong, supported by expanding healthcare infrastructure in emerging economies and integration of AI-driven analytics in diagnostic workflows. The innovation landscape is dynamic, with a focus on automation, miniaturization, and point-of-care solutions. However, demand-supply imbalances persist, particularly in low-resource regions, where supply chain constraints hinder access to cutting-edge equipment. Key risks include regulatory uncertainties, reimbursement challenges, and technological obsolescence, which could impact market stability. Decision-makers must prioritize agile strategies to navigate these factors and capitalize on high-growth opportunities.

12 items

1. Executive Summary

2. Immunodiagnostic Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Immunodiagnostic Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Immunodiagnostic Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Immunodiagnostic Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Immunodiagnostic Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Immunodiagnostic Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Immunodiagnostic Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Immunodiagnostic Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Immunodiagnostic Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Immunodiagnostic Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Immunodiagnostic Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Immunodiagnostic Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Immunodiagnostic Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Immunodiagnostic Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Immunodiagnostic Equipment Market Competition by Key Manufacturers

9.1. Global Immunodiagnostic Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Immunodiagnostic Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Immunodiagnostic Equipment Market

Figure 4: Global Immunodiagnostic Equipment Market: Drivers

Figure 5: Global Immunodiagnostic Equipment Market: Challenges

Figure 6: Global Immunodiagnostic Equipment Market: Trends

Figure 7: Global Immunodiagnostic Equipment Market: Opportunity

Figure 8: Global Immunodiagnostic Equipment Market: Restraint

Figure 9: Global Immunodiagnostic Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Immunodiagnostic Equipment Market Value (USD Million) By Region

Figure 19: Global Immunodiagnostic Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Immunodiagnostic Equipment Market Value (USD Million) By Region

Figure 27: Global Immunodiagnostic Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Immunodiagnostic Equipment Market Volume (K) By Region

Figure 29: Global Immunodiagnostic Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Immunodiagnostic Equipment Market Value (USD Million) By Region

Figure 37: Global Immunodiagnostic Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Immunodiagnostic Equipment Market Volume (K) By Region

Figure 39: Global Immunodiagnostic Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Immunodiagnostic Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Immunodiagnostic Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Immunodiagnostic Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Immunodiagnostic Equipment Market Value (USD Million) By Region

Table 14: Global Immunodiagnostic Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Immunodiagnostic Equipment Market Volume (K) By Region

Table 31: Global Immunodiagnostic Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Immunodiagnostic Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Immunodiagnostic Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Immunodiagnostic Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Global Market Value (USD Million) (2025-2032) By Application

Table 52: Global Market Share (%) By Application (2032)

Table 53: Global Market Value (USD Million) (2025-2032) By Types

Table 54: Global Market Share (%) By Types (2032)

Table 55: Global Market Volume (K) (2025-2032) By Application

Table 56: Global Market Share (%) By Application (2032)

Table 57: Global Market Volume (K) (2025-2032) By Types

Table 58: Global Market Share (%) By Types (2032)

Table 59: Global Immunodiagnostic Equipment Market Value (USD Million) By Region

Table 60: Global Immunodiagnostic Equipment Market Share (%) By Region (2025-2032)

Table 61: North America Market Value (USD Million) (2025-2032) By Country

Table 62: North America Market Value (USD Million) (2025-2032) By Application

Table 63: North America Market Value (USD Million) (2025-2032) By Types

Table 64: Europe Market Value (USD Million) (2025-2032) By Country

Table 65: Europe Market Value (USD Million) (2025-2032) By Application

Table 66: Europe Market Value (USD Million) (2025-2032) By Types

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 70: South America Market Value (USD Million) (2025-2032) By Country

Table 71: South America Market Value (USD Million) (2025-2032) By Application

Table 72: South America Market Value (USD Million) (2025-2032) By Types

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 76: Global Immunodiagnostic Equipment Market Volume (K) By Region

Table 77: Global Immunodiagnostic Equipment Market Share (%) By Region (2025-2032)

Table 78: North America Market Volume (K) (2025-2032) By Country

Table 79: North America Market Volume (K) (2025-2032) By Application

Table 80: North America Market Volume (K) (2025-2032) By Types

Table 81: Europe Market Volume (K) (2025-2032) By Country

Table 82: Europe Market Volume (K) (2025-2032) By Application

Table 83: Europe Market Volume (K) (2025-2032) By Types

Table 84: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 85: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 86: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 87: South America Market Volume (K) (2025-2032) By Country

Table 88: South America Market Volume (K) (2025-2032) By Application

Table 89: South America Market Volume (K) (2025-2032) By Types

Table 90: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 91: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 92: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Immunodiagnostic Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.79 billion
Revenue forecast in 2033	3.13 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acuity Inc.; Cree Lighting USA LLC.; Samsung Electronics; Signify Holding; OSRAM GmbH; Savant Systems, Inc.; Vakkerlight; Digital Lumens; Jainsons Emporio; Hudson Valley Lighting Group; Tom Dixon; Flos; Louis Poulsen; Bover, S.L.; Vibia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options